Addex Therapeutics Ltd logo

Addex Therapeutics Ltd

ADXN | NASDAQ
Chart Builder DCF Calculator
$3.53
+$0.13 (+3.98%)
At close: Sep 21, 2026, 4:00 PM ET
$3.31
-$0.22 (-6.23%)
After-hours: Sep 21, 2026, 7:45 PM ET

Market Data

Market Cap
$4.19M
Enterprise Value
$2.64M
Beta
1.96
Average Volume
94.79K
Shares Outstanding (Diluted)
1.43M
Shares Change YoY
74.12%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US00654J2069

Price Performance

Price Change 1M
-20.9%
Price Change 3M
-45.3%
Price Change 6M
-45.8%
Price Change YTD
-56.4%
Price Change 1Y
-63.5%
Price Change 3Y
-51.8%
Price Change 5Y
-98.2%
1M CAGR (ann.)
-41.4%
1Y CAGR (ann.)
-68.7%
5Y CAGR (ann.)
-55.1%
All-Time CAGR
-47.0%

Valuation

PE Ratio
-0.42
Forward PE
N/A
PEG Ratio
0.00
Forward PEG
0.02
PS Ratio
47.09
Forward PS
0.60
PB Ratio
1.06
P/FCF Ratio
-1.50
P/Adj. FCF Ratio
-1.48
P/OCF Ratio
-1.73
EV/Sales
35.65
EV/EBIT
-0.37
EV/EBITDA
-0.37
EV/FCF
-1.13
Earnings Yield
-234.7%
FCF Yield
-65.2%
Adj. FCF Yield
-65.8%

Financial Health

Net Cash
CHF937.5K
Total Debt
CHF102.27K
Cash & Short-Term Investments
CHF937.5K
Total Assets
CHF4.76M
Current Ratio
0.97
Quick Ratio
0.97
Debt / Equity Ratio
0.03
Debt / EBITDA
-0.01
Debt / FCF
-0.04
OCF / Debt
-22.76
Interest Coverage
-145.69
Altman Z-Score
-109.97
Piotroski F-Score
1

Margins & Profitability

Gross Profit Margin
84.3%
Operating Profit Margin
-3630.8%
EBITDA Margin
-5331.1%
Net Profit Margin
-7775.2%
FCF Margin
-3143.4%
Adj. FCF Margin
-3174.3%
SBC / Revenue
25.6%
SBC Impact (per share)
-1.0%

Returns

Return on Assets
-146.4%
Return on Equity
-131.3%
Return on Invested Capital
-74.4%
Return on Capital Employed
-76.0%
Return on Tangible Assets
-146.4%

Historical Growth (CAGR)

Revenue CAGR 3Y
-64.7%
Revenue CAGR 5Y
-53.9%
Revenue CAGR 10Y
-22.0%
EPS CAGR 3Y
110.4%
EPS CAGR 5Y
70.0%
EPS CAGR 10Y
10.1%
FCF CAGR 3Y
59.2%
FCF CAGR 5Y
43.8%
FCF CAGR 10Y
-5.6%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
1
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 8, 2026
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$30
Price Target Upside
749.9%

Cash Flow

Operating Cash Flow
CHF-2.33M
Free Cash Flow
CHF-2.33M
Adj. Free Cash Flow
CHF-2.35M
FCF Per Share
-$1.64
OCF Per Share
-$1.64
OCF/S Ratio
-2609.7%

Income Statement

Revenue
CHF74.04K
Gross Profit
CHF-196.55K
Operating Income
CHF-2.69M
EBITDA
CHF-7.06M
Net Income
CHF-6.97M
EPS (Diluted)
-$6.80
Revenue / Employee
$24.68K
Profit / Employee
$-2.32M
Employees
3

© 2026 bestshares.com. All rights reserved.